Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Pruis MA"'
Autor:
Pruis MA; Department of Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Plummer R; Oncology Department, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle, UK., De Vos F; Department Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands., Angevin E; Drug Development Department (DITEP), Gustave Roussy Institute, Villejuif, France., Prenen H; Department of Medical Oncology, University Hospital Antwerp, Antwerp, Belgium., Forster MD; Department of Oncology, UCL Cancer Institute/ University College London Hospitals NHS Foundation Trust, London, UK., Clack G; Octimet Oncology NV, Belgium., Van der Aa A; Octimet Oncology NV, Belgium., Tjwa M; Octimet Oncology NV, Belgium., Jansen E; Octimet Oncology NV, Belgium., Perera T; Department of Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Octimet Oncology NV, Belgium., Lolkema MP; Department of Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
The oncologist [Oncologist] 2023 Dec 11; Vol. 28 (12), pp. e1248-e1258.
Autor:
de Leeuw SP; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Pruis MA; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Sikkema BJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Mohseni M; Department of Internal Medicine, Division of Endocrinology and Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Veerman GDM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Paats MS; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Dumoulin DW; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Smit EF; Department of Pulmonary Medicine, Leiden University Medical Center, Leiden, The Netherlands., Schols AMWJ; School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Rossum EFC; Department of Internal Medicine, Division of Endocrinology and Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Dingemans AC; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: a.dingemans@erasmusmc.nl.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Aug; Vol. 18 (8), pp. 1017-1030. Date of Electronic Publication: 2023 Mar 29.
Autor:
Pruis MA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands.; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands., Veerman GDM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands., Hassing HC; Department of Cardiology, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands., Lanser DAC; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands., Paats MS; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands., Manintveld O; Department of Cardiology, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands., Dingemans AC; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands.
Publikováno v:
JACC. CardioOncology [JACC CardioOncol] 2023 Jan 17; Vol. 5 (1), pp. 102-113. Date of Electronic Publication: 2023 Jan 17 (Print Publication: 2023).
Autor:
de Rouw N; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.; Department of Pharmacy, Jeroen Bosch Hospital, 'S-Hertogenbosch, The Netherlands., Boosman RJ; Department of Pharmacy & Pharmacology, Antoni Van Leeuwenhoek-The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. r.boosman@nki.nl., Burgers JA; Department of Thoracic Oncology, Antoni Van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, Antoni Van Leeuwenhoek-The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, Utrecht University Medical Center, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Dingemans AC; Department of Pulmonary Diseases, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Derijks HJ; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.; Department of Pharmacy, Jeroen Bosch Hospital, 'S-Hertogenbosch, The Netherlands., Burger DM; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands., Piet B; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands., Hendriks LEL; Department of Pulmonary Diseases, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., Biesma B; Department of Pulmonary Diseases, Jeroen Bosch Hospital, 's Hertogenbosch, The Netherlands., Pruis MA; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Dumoulin DW; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Croes S; Department of Clinical Pharmacy & Toxicology, CARIM-School for Cardiovascular Disease, Maastricht University Medical Centre, Maastricht, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van den Heuvel MM; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands., Ter Heine R; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2023 Jan; Vol. 91 (1), pp. 33-42. Date of Electronic Publication: 2022 Nov 21.
Autor:
Pruis MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Groenendijk FH; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Badloe KS; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., van Puffelen A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Robbrecht D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Dinjens WNM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Dingemans AC; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, Netherlands., von der Thüsen JH; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Roepman P; Hartwig Medical Foundation, Amsterdam, Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands. m.lolkema@erasmusmc.nl.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Sep; Vol. 127 (4), pp. 776-783. Date of Electronic Publication: 2022 May 23.
Autor:
Pruis MA; Department of Respiratory Medicine, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Paats MS; Department of Respiratory Medicine, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Geurts WRR; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Dingemans AC; Department of Respiratory Medicine, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2021 Nov; Vol. 5, pp. 849-853.
Autor:
Pruis MA; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hussain B; Department of Radiology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Bakker M; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hoek RAS; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Miedema JR; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Dingemans AC; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Paats MS; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: m.paats@erasmusmc.nl.
Publikováno v:
Cancer cell [Cancer Cell] 2020 Nov 09; Vol. 38 (5), pp. 611-612. Date of Electronic Publication: 2020 Oct 09.
Autor:
Pruis MA; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., von der Thüsen JH; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Publikováno v:
Annals of translational medicine [Ann Transl Med] 2020 Nov; Vol. 8 (22), pp. 1538.
Autor:
Steendam CMJ; Department of Pulmonology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Pulmonology, Amphia Hospital, 4818 CK Breda, The Netherlands., Veerman GDM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Pruis MA; Department of Pulmonology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Atmodimedjo P; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Paats MS; Department of Pulmonology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., van der Leest C; Department of Pulmonology, Amphia Hospital, 4818 CK Breda, The Netherlands., von der Thüsen JH; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Yick DCY; Department of Pathology, Amphia Hospital, 4818 CK Breda, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Dinjens WNM; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Aerts JGJV; Department of Pulmonology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands., Dingemans AC; Department of Pulmonology, Erasmus MC Cancer Institute, University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Pulmonology, Maastricht UMC+, 6229 HX Maastricht, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Oct 29; Vol. 12 (11). Date of Electronic Publication: 2020 Oct 29.
Autor:
Pruis MA; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Geurts-Giele WRR; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., von der TJH; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Meijssen IC; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Dinjens WNM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Aerts JGJV; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Dingemans AMC; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Pulmonary Diseases, Maastricht UMC +, Maastricht, the Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Paats MS; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: h.dubbink@erasmusmc.nl.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2020 Feb; Vol. 140, pp. 46-54. Date of Electronic Publication: 2019 Nov 18.